Insider Trading: Sequenom Inc (SQNM.O)

SQNM.O on Nasdaq

4.03USD
24 May 2013
Price Change (% chg)

$-0.05 (-1.23%)
Prev Close
$4.08
Open
$4.04
Day's High
$4.09
Day's Low
$3.98
Volume
984,634
Avg. Vol
2,742,733
52-wk High
$5.36
52-wk Low
$2.65

Search Stocks
LINDSAY RONALD M
Trading Date Type Shares Traded Price Shares Held
31 Jul 2012 Buy 3,300 $2.93 167,243
31 Jul 2012 Buy 2,600 $2.95 167,243
31 Jul 2012 Buy 1,000 $2.96 167,243
31 Jul 2012 Buy 1,100 $2.92 167,243
31 Jul 2012 Buy 600 $2.99 167,243
31 Jul 2012 Buy 335 $2.90 167,243
31 Jul 2012 Buy 400 $2.97 167,243
31 Jul 2012 Buy 88,765 $3.00 167,243
31 Jul 2012 Buy 1,900 $2.87 167,243
6 Feb 2012 Buy 1,001 $0.00 67,243
6 Feb 2012 Sell 359 $4.92 67,243
6 Feb 2012 Buy 4,000 $0.00 67,243
6 Feb 2012 Sell 1,436 $4.92 67,243
6 Feb 2012 Buy 4,000 $0.00 67,243
6 Feb 2012 Sell 1,436 $4.92 67,243
6 Nov 2011 Buy 11,200 $4.24 57,950
6 Nov 2011 Buy 8,800 $4.23 57,950
17 Jul 2011 Buy 4,999 $0.00 36,281
17 Jul 2011 Sell 1,587 $7.46 36,281
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 73.95%
# of Holders: 170
Total Shares Held: 85,159,293
3 Mo. Net Change: 2,054,939
# New Positions: 23
# Closed Positions: 23
# Increased Positions: 78
# Reduced Positions: 64
# Net Buyers: 14

Officers & Directors

Name Age Since Current Position

Harry Hixson

 74 2009 Chairman of the Board, Chief Executive Officer

William Welch

 51 2012 President, Chief Operating Officer

Paul Maier

 65 2009 Chief Financial Officer

Dirk van den Boom

 42 2012 Executive Vice President - Research and Development, Chief Technology Officer

Ronald Lindsay

 65 2012 Executive Vice President - Strategic Planning, Director

Bill Bowen

 60 2012 Senior Vice President, General Counsel, Secretary

Michael Monko

 53 2011 Senior Vice President - Genetic Analysis

Robin Weiner

 57 2010 Senior Vice President - Quality and Regulatory Affairs

Charles Cantor

 70 2010 Chief Scientific Officer

Carolyn Beaver

 55 2012 Vice President, Chief Accounting Officer

Alisa Judge

 57 2007 Vice President - Human Resources

Allan Bombard

 60 2009 Chief Medical Officer

Richard Lerner

 74 2010 Lead Independent Director

Myla Lai-Goldman

 2012 Director

Ernst Guenter Afting

 70 1996 Independent Director

Kenneth Buechler

 59 2009 Independent Director

John Fazio

 68 2007 Independent Director

David Pendarvis

 53 2009 Independent Director

Charles Slacik

 58 2011 Independent Director

Marcy Graham

 Senior Director, Investor Relations and Corporate Communications
Search Stocks